[HTML][HTML] T2 mapping in myocardial disease: a comprehensive review

AT O'Brien, KE Gil, J Varghese, OP Simonetti… - Journal of …, 2022 - Elsevier
Cardiovascular magnetic resonance (CMR) is considered the gold standard imaging
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations

D Verhaert, K Richards, JA Rafael-Fortney… - Circulation …, 2011 - Am Heart Assoc
Muscular dystrophy (MD) connotes a heterogeneous group of inherited disorders
characterized by progressive wasting and weakness of the skeletal muscles. In several …

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS

I Arpan, RJ Willcocks, SC Forbes, RS Finkel, DJ Lott… - Neurology, 2014 - AAN Enterprises
Objective: To evaluate the effects of corticosteroids on the lower extremity muscles in boys
with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance …

Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression

RJ Willcocks, IA Arpan, SC Forbes, DJ Lott… - Neuromuscular …, 2014 - Elsevier
Duchenne muscular dystrophy (DMD) is characterized by an increased muscle damage and
progressive replacement of muscle by noncontractile tissue. Both of these pathological …

T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross‐sectional study of lower leg muscles in …

I Arpan, SC Forbes, DJ Lott, CR Senesac… - NMR in …, 2013 - Wiley Online Library
Skeletal muscles of children with Duchenne muscular dystrophy (DMD) show enhanced
susceptibility to damage and progressive lipid infiltration, which contribute to an increase in …

[HTML][HTML] Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left …

KN Hor, MD Taylor, HR Al-Khalidi, LH Cripe… - Journal of …, 2013 - Elsevier
Background Duchenne muscular dystrophy (DMD), an X-linked disorder affects
approximately 1 in 5000 males, is universally associated with heart disease. We previously …

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial

GM Buyse, N Goemans, M van den Hauwe… - Neuromuscular …, 2011 - Elsevier
Early mortality in Duchenne muscular dystrophy (DMD) is related to cardiac and respiratory
complications. A phase IIa double-blind randomized placebo-controlled clinical trial was …

Cardiac MRI biomarkers for Duchenne muscular dystrophy

P Magrath, N Maforo, P Renella, SF Nelson… - Biomarkers in …, 2018 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is a fatal inherited genetic disorder that results in
progressive muscle weakness and ultimately loss of ambulation, respiratory failure and …

Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment

K Andrysiak, G Machaj, D Priesmann… - Cardiovascular …, 2024 - academic.oup.com
Aims Duchenne muscular dystrophy (DMD)-associated cardiomyopathy is a serious life-
threatening complication, the mechanisms of which have not been fully established, and …

[HTML][HTML] Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response

S Gandhi, HL Sweeney, CC Hart, R Han, CGR Perry - Cells, 2024 - mdpi.com
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …